Clinical particularities of pregnancy in the periodic disease and special considerations in the prenatal care

Cover Page

Abstract


The problem of studying the periodic disease (PD) has almost a centennial history. A new stage in diagnosing and evaluating the prevalence of the PD in various populations was due to an essential discovery of the MEFV (MEditerranean FeVer) gene localized in the chromosome 16p13.3. Colchicine remains the only officially accepted medicine for PD treatment and renal amyloidosis prevention. However, from the perspective of the perinatal pharmacotherapy with a glance to colchicine’s teratogenic effect its use in obstetrics is inappropriate.

About the authors

R A Abramyan

Institute of Perinatology, Obstetrics and Gynecology Republic of Armenia Healthcare Ministry

Email: ipog@radionet.am

G S Avagyan

Institute of Perinatology, Obstetrics and Gynecology Republic of Armenia Healthcare Ministry

Email: ipog@radionet.am

L R Abramyan

Institute of Perinatology, Obstetrics and Gynecology Republic of Armenia Healthcare Ministry

Email: ipog@radionet.am

References

Statistics

Views

Abstract - 113

PDF (Russian) - 166

Cited-By



Copyright (c) 2011 Абрамян Р.А., Авагян Г.С., Абрамян Л.Р.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies